GGrantIndex
← Leaderboards

Amy Brock

University Of Texas At Austin

$4,569,668
Attributed
$8,580,144
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,580,144 · 5

By mechanism

R01$4,739,551 · 2
U01$2,142,610 · 1
R33$1,138,792 · 1
R21$559,191 · 1

Top collaborators

Most similar at University Of Texas At Austin

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Cells

Research focus

CellsMalignant NeoplasmsNeoplastic CellTumorLinkBehaviorCell DimensionGrowthPhenotypeDiagnosisHeterogeneityMeasurementTranscriptomeCommunitiesExperimental StudyTranscriptomicsTumor HeterogeneityMapsCancer CellHigh DimensionalityGene ExpressionBar CodesCell CountGenomics

Grant awards (26)

Instability of Cancer Cell States in Tumor progression (ICCS)$507,800
R01 · FY2025 · CA
Instability of Cancer Cell States in Tumor progression (ICCS)$474,027
R01 · FY2024 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$1
U01 · FY2024 · CA · contact PI
Instability of Cancer Cell States in Tumor progression (ICCS)$486,752
R01 · FY2023 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$421,433
U01 · FY2023 · CA · contact PI
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells$370,830
R33 · FY2023 · CA
Using label-free Raman microscopy to predict therapeutic resistance of TNBC cells$143,802
U01 · FY2023 · CA · contact PI
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$79,365
U01 · FY2023 · CA · contact PI
Instability of Cancer Cell States in Tumor progression (ICCS)$479,404
R01 · FY2022 · CA
The Allee Effect in Tumor Initiation$439,171
R01 · FY2022 · CA · contact PI
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$421,433
U01 · FY2022 · CA · contact PI
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells$373,068
R33 · FY2022 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$79,365
U01 · FY2022 · CA · contact PI
Instability of Cancer Cell States in Tumor progression (ICCS)$509,003
R01 · FY2021 · CA
The Allee Effect in Tumor Initiation$452,983
R01 · FY2021 · CA · contact PI
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$430,034
U01 · FY2021 · CA · contact PI
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells$394,894
R33 · FY2021 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$80,986
U01 · FY2021 · CA · contact PI
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$42,877
U01 · FY2021 · CA · contact PI
The Allee Effect in Tumor Initiation$457,832
R01 · FY2020 · CA · contact PI
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$443,314
U01 · FY2020 · CA · contact PI
The Allee Effect in Tumor Initiation$449,991
R01 · FY2019 · CA · contact PI
High resolution cell lineage tracking and isolation$182,631
R21 · FY2019 · CA · contact PI
The Allee Effect in Tumor Initiation$482,588
R01 · FY2018 · CA · contact PI
High resolution cell lineage tracking and isolation$188,280
R21 · FY2018 · CA · contact PI
High resolution cell lineage tracking and isolation$188,280
R21 · FY2017 · CA · contact PI